Choose a language and wait for the translated text.
Shots:
Rockwell Medical has entered into an equity & asset purchase agreement to acquire Vantive‘s hemodialysis (HD) concentrates, HD machines (incl. AK-98), water treatment systems and related consumables & technical services business
As per the deal, Vantive will receive a base purchase price of $125M, financed via two $50M term loans from Vantive & a $25M convertible note, along with up to $45M in contingent payments based on revenue & EBITDA milestones
Rockwell will also acquire Vantive’s ~1M sq. ft. manufacturing campus in Medolla, Italy; the combined business is projected to generate $400-450M in annual revenue, with the deal expected to close in mid-2027
Ref: Rockwell Medical | Image: Rockwell Medical & Vantive | Press Release
PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com
The post Rockwell Medical to Acquire Vantive’s Global Hemodialysis Business for Up to $170M appeared first on PharmaShots.
Rockwell Medical to Acquire Vantive’s Global Hemodialysis Business for Up to $170M | PharmaVoice